What's New With the BMT Group?

Two systematic, evidence-based reviews (EBRs) authored by Denise Oliansky, Dr. Hahn, and Dr. McCarthy of the RPCI BMT Program, have recently been published in Biology of Blood and Marrow Transplantation. The sixth in a series of EBRs written by the BMT group in collaboration with the American Society of Blood and Marrow Transplantation,"The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myeloid Leukemia in Adults: An Evidence-Based Review" was published in February, 2008, and was co-authored with Frederick Appelbaum, Fred Hutchinson Cancer Institute, Seattle, Washington; Peter A. Cassileth, University of Miami Sylvester Cancer Center, Miami, Florida; Armand Keating, University of Toronto, Toronto, ON, Canada; Jamie Kerr, Excellus Blue Cross/Blue Shield, Rochester, New York; Yago Nieto, M.D. Anderson Cancer Center, Houston, Texas; Susan Stewart, BMT Infonet, Chicago, Illinois; Richard M. Stone, Dana Farber Cancer Institute, Boston, Massachusetts; and Martin S. Tallman, Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois.

The seventh EBR in the series, "The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Myelodysplastic Syndromes: An Evidence-Based Review" was published in February, 2009, and was co-authored with Joseph H. Antin, Dana Farber Cancer Institute, Boston, MA; John M. Bennett, University of Rochester, James P. Wilmot Cancer Center, Rochester, NY; H. Joachim Deeg, Fred Hutchinson Cancer Research Center, Seattle, WA; Christin Engelhardt, Aplastic Anemia and MDS International Foundation, Inc., Churchton, MD; Kathleen V. Heptinstall, The Myelodysplastic Syndromes Foundation, Inc., Crosswicks, NJ; Marcos de Lima, MD Anderson Cancer Center, Houston, TX; Steven D. Gore, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Ronald G. Potts, INTERLINK Health Services, Hillsboro, OR;Lewis R. Silverman, Mt. Sinai School of Medicine, New York, NY; and Roy B. Jones, MD Anderson Cancer Center, Houston, TX.